HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: Possible pathway for HIV entry into the brain and HIV-associated dementia

Georgette D. Kanmogne, R. C. Kennedy, Paula Grammas

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Breakdown of the blood-brain barrier is commonly seen in patients with human immunodeficiency virus (HIV)-associated dementia, despite the lack of productive HIV-infection of the brain endothelium. Through this damaged blood-brain barrier, HIV and HIV-infected monocytes/macrophages infiltrate the brain and further infect microglia and brain macrophages. Neuronal cell death and dysfunction are the underlying cause of HIV-associated dementia, but no productive HIV-infection of neurons has been documented. It is likely that secreted viral products play a major role in blood-brain barrier damage and neuronal cell death. The aim of the present study was to examine the effect of HIV-1 gp160 peptides and gp120 proteins on brain microvascular endothelial cells and neurons from both human and rats. Four of the 7 gp160 peptides tested evoked significant neurotoxicity. Two different full-length recombinant HIV gp120 proteins (HIV-1CM235 gp120 and HIV-1MN gp120) also induced neuronal and brain endothelial cell death, and concentrations as little as 1 ng/ml evoked pronounced morphological changes in these cells and marked cytotoxicity. This study suggests that HIV proteins and peptides that are shed in vivo may be directly involved in blood-brain barrier damage and neuronal cell death in HIV-associated dementia.

Original languageEnglish (US)
Pages (from-to)992-1000
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume61
Issue number11
DOIs
StatePublished - Nov 1 2002

Fingerprint

Virus Internalization
Poisons
Dementia
Endothelial Cells
HIV
Neurons
Peptides
Brain
Blood-Brain Barrier
Cell Death
Human Immunodeficiency Virus Proteins
Virus Diseases
Macrophages
Human immunodeficiency virus 1 gp120 protein
Microglia
Recombinant Proteins
Endothelium
Monocytes

Keywords

  • Brain endothelial cells
  • HIV-1
  • HIV-associated dementia
  • Neurons
  • gp120 proteins
  • gp160 peptides

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{8a8e844cbcf44959b81368449db01dc0,
title = "HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: Possible pathway for HIV entry into the brain and HIV-associated dementia",
abstract = "Breakdown of the blood-brain barrier is commonly seen in patients with human immunodeficiency virus (HIV)-associated dementia, despite the lack of productive HIV-infection of the brain endothelium. Through this damaged blood-brain barrier, HIV and HIV-infected monocytes/macrophages infiltrate the brain and further infect microglia and brain macrophages. Neuronal cell death and dysfunction are the underlying cause of HIV-associated dementia, but no productive HIV-infection of neurons has been documented. It is likely that secreted viral products play a major role in blood-brain barrier damage and neuronal cell death. The aim of the present study was to examine the effect of HIV-1 gp160 peptides and gp120 proteins on brain microvascular endothelial cells and neurons from both human and rats. Four of the 7 gp160 peptides tested evoked significant neurotoxicity. Two different full-length recombinant HIV gp120 proteins (HIV-1CM235 gp120 and HIV-1MN gp120) also induced neuronal and brain endothelial cell death, and concentrations as little as 1 ng/ml evoked pronounced morphological changes in these cells and marked cytotoxicity. This study suggests that HIV proteins and peptides that are shed in vivo may be directly involved in blood-brain barrier damage and neuronal cell death in HIV-associated dementia.",
keywords = "Brain endothelial cells, HIV-1, HIV-associated dementia, Neurons, gp120 proteins, gp160 peptides",
author = "Kanmogne, {Georgette D.} and Kennedy, {R. C.} and Paula Grammas",
year = "2002",
month = "11",
day = "1",
doi = "10.1093/jnen/61.11.992",
language = "English (US)",
volume = "61",
pages = "992--1000",
journal = "Journal of Neuropathology and Experimental Neurology",
issn = "0022-3069",
number = "11",

}

TY - JOUR

T1 - HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons

T2 - Possible pathway for HIV entry into the brain and HIV-associated dementia

AU - Kanmogne, Georgette D.

AU - Kennedy, R. C.

AU - Grammas, Paula

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Breakdown of the blood-brain barrier is commonly seen in patients with human immunodeficiency virus (HIV)-associated dementia, despite the lack of productive HIV-infection of the brain endothelium. Through this damaged blood-brain barrier, HIV and HIV-infected monocytes/macrophages infiltrate the brain and further infect microglia and brain macrophages. Neuronal cell death and dysfunction are the underlying cause of HIV-associated dementia, but no productive HIV-infection of neurons has been documented. It is likely that secreted viral products play a major role in blood-brain barrier damage and neuronal cell death. The aim of the present study was to examine the effect of HIV-1 gp160 peptides and gp120 proteins on brain microvascular endothelial cells and neurons from both human and rats. Four of the 7 gp160 peptides tested evoked significant neurotoxicity. Two different full-length recombinant HIV gp120 proteins (HIV-1CM235 gp120 and HIV-1MN gp120) also induced neuronal and brain endothelial cell death, and concentrations as little as 1 ng/ml evoked pronounced morphological changes in these cells and marked cytotoxicity. This study suggests that HIV proteins and peptides that are shed in vivo may be directly involved in blood-brain barrier damage and neuronal cell death in HIV-associated dementia.

AB - Breakdown of the blood-brain barrier is commonly seen in patients with human immunodeficiency virus (HIV)-associated dementia, despite the lack of productive HIV-infection of the brain endothelium. Through this damaged blood-brain barrier, HIV and HIV-infected monocytes/macrophages infiltrate the brain and further infect microglia and brain macrophages. Neuronal cell death and dysfunction are the underlying cause of HIV-associated dementia, but no productive HIV-infection of neurons has been documented. It is likely that secreted viral products play a major role in blood-brain barrier damage and neuronal cell death. The aim of the present study was to examine the effect of HIV-1 gp160 peptides and gp120 proteins on brain microvascular endothelial cells and neurons from both human and rats. Four of the 7 gp160 peptides tested evoked significant neurotoxicity. Two different full-length recombinant HIV gp120 proteins (HIV-1CM235 gp120 and HIV-1MN gp120) also induced neuronal and brain endothelial cell death, and concentrations as little as 1 ng/ml evoked pronounced morphological changes in these cells and marked cytotoxicity. This study suggests that HIV proteins and peptides that are shed in vivo may be directly involved in blood-brain barrier damage and neuronal cell death in HIV-associated dementia.

KW - Brain endothelial cells

KW - HIV-1

KW - HIV-associated dementia

KW - Neurons

KW - gp120 proteins

KW - gp160 peptides

UR - http://www.scopus.com/inward/record.url?scp=0036840387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840387&partnerID=8YFLogxK

U2 - 10.1093/jnen/61.11.992

DO - 10.1093/jnen/61.11.992

M3 - Article

C2 - 12430716

AN - SCOPUS:0036840387

VL - 61

SP - 992

EP - 1000

JO - Journal of Neuropathology and Experimental Neurology

JF - Journal of Neuropathology and Experimental Neurology

SN - 0022-3069

IS - 11

ER -